These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20647500)

  • 1. Heterogeneous treatment effects: what does a regression estimate?
    Rhodes W
    Eval Rev; 2010 Aug; 34(4):334-61. PubMed ID: 20647500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weaknesses of goodness-of-fit tests for evaluating propensity score models: the case of the omitted confounder.
    Weitzen S; Lapane KL; Toledano AY; Hume AL; Mor V
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):227-38. PubMed ID: 15386700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting treatment-effect estimates with heterogeneity and choice: simulation model results.
    Brooks JM; Fang G
    Clin Ther; 2009 Apr; 31(4):902-19. PubMed ID: 19446162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic differences in treatment effect estimates between propensity score methods and logistic regression.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are propensity scores really superior to standard multivariable analysis?
    Biondi-Zoccai G; Romagnoli E; Agostoni P; Capodanno D; Castagno D; D'Ascenzo F; Sangiorgi G; Modena MG
    Contemp Clin Trials; 2011 Sep; 32(5):731-40. PubMed ID: 21616172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apples and oranges? Interpretations of risk adjustment and instrumental variable estimates of intended treatment effects using observational data.
    Fang G; Brooks JM; Chrischilles EA
    Am J Epidemiol; 2012 Jan; 175(1):60-5. PubMed ID: 22085626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study.
    Austin PC; Grootendorst P; Normand SL; Anderson GM
    Stat Med; 2007 Feb; 26(4):754-68. PubMed ID: 16783757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring balance and model selection in propensity score methods.
    Belitser SV; Martens EP; Pestman WR; Groenwold RH; de Boer A; Klungel OH
    Pharmacoepidemiol Drug Saf; 2011 Nov; 20(11):1115-29. PubMed ID: 21805529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian propensity score analysis for observational data.
    McCandless LC; Gustafson P; Austin PC
    Stat Med; 2009 Jan; 28(1):94-112. PubMed ID: 19012268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.
    Arbogast PG; Ray WA
    Am J Epidemiol; 2011 Sep; 174(5):613-20. PubMed ID: 21749976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of propensity scores using generalized additive models.
    Woo MJ; Reiter JP; Karr AF
    Stat Med; 2008 Aug; 27(19):3805-16. PubMed ID: 18366144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weighting regressions by propensity scores.
    Freedman DA; Berk RA
    Eval Rev; 2008 Aug; 32(4):392-409. PubMed ID: 18591709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The performance of random coefficient regression in accounting for residual confounding.
    Gustafson P; Greenland S
    Biometrics; 2006 Sep; 62(3):760-8. PubMed ID: 16984318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score.
    Austin PC
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1202-17. PubMed ID: 18972454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating health management programmes over time: application of propensity score-based weighting to longitudinal data.
    Linden A; Adams JL
    J Eval Clin Pract; 2010 Feb; 16(1):180-5. PubMed ID: 20367830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to assess intended effects of drug treatment in observational studies are reviewed.
    Klungel OH; Martens EP; Psaty BM; Grobbee DE; Sullivan SD; Stricker BH; Leufkens HG; de Boer A
    J Clin Epidemiol; 2004 Dec; 57(12):1223-31. PubMed ID: 15617947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the estimation and use of propensity scores in case-control and case-cohort studies.
    Månsson R; Joffe MM; Sun W; Hennessy S
    Am J Epidemiol; 2007 Aug; 166(3):332-9. PubMed ID: 17504780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.